ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Bidyut Ghosh
Matched on ORCID iD 0009-0004-6730-6474; OpenAlex author ID A5112482844, A5121963197. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2767-9764.crc-25-0278↗
- Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2021.12.273↗
- Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment. Co-author DOI 10.1158/2159-8290.cd-19-0297↗
- A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination. Last author DOI 10.1038/s41374-018-0171-z↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anirban Maitra · 4 shared papers, 2019–2026 · strength 0.57
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278↗
- Paper Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocar… DOI 10.1053/j.gastro.2021.12.273↗
- Paper A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-me… DOI 10.1038/s41374-018-0171-z↗
- Huamin Wang · 2 shared papers, 2020–2026 · strength 0.35
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278↗
- Paper Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenviron… DOI 10.1158/2159-8290.cd-19-0297↗
- Haoqiang Ying · 2 shared papers, 2020–2026 · strength 0.35
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278↗
- Paper Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenviron… DOI 10.1158/2159-8290.cd-19-0297↗
- MennatAllah Shaheen · 1 shared paper, 2026 · strength 0.27
- Ching-Fei Li · 1 shared paper, 2026 · strength 0.27
- Benson Chellakkan Selvanesan · 1 shared paper, 2026 · strength 0.27
- Takashi Okumura · 2 shared papers, 2019–2022 · strength 0.22
- Paper Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocar… DOI 10.1053/j.gastro.2021.12.273↗
- Paper A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-me… DOI 10.1038/s41374-018-0171-z↗
- Lotfi Abou‐Elkacem · 1 shared paper, 2022 · strength 0.13
- Jason Roszik · 1 shared paper, 2022 · strength 0.13
- Maria E. Monberg · 1 shared paper, 2022 · strength 0.13
- Paola A. Guerrero · 1 shared paper, 2022 · strength 0.13
- Mohamed Zaid · 1 shared paper, 2022 · strength 0.13
- Abdel Nasser Hosein · 1 shared paper, 2022 · strength 0.13
- Hans C. Clevers · 1 shared paper, 2022 · strength 0.13
- Aatur Dilip Singhi · 1 shared paper, 2022 · strength 0.13
- Sonal Gupta · 1 shared paper, 2019 · strength 0.09
- Noboru Ideno · 1 shared paper, 2019 · strength 0.09
- Jianhua Zhang · 1 shared paper, 2020 · strength 0.08
- Giannicola Genovese · 1 shared paper, 2020 · strength 0.08
- Vincent Bernard · 1 shared paper, 2020 · strength 0.08
- Pat Gulhati · 1 shared paper, 2020 · strength 0.08
- Nagireddy Putluri · 1 shared paper, 2020 · strength 0.08
- Ronald Anthony Depinho · 1 shared paper, 2020 · strength 0.08
- Prasenjit Dey · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.